BIOX logo

BIOX
Bioceres Crop Solutions Corp

951
Mkt Cap
$102.81M
Volume
416,626.00
52W High
$7.44
52W Low
$1.20
PE Ratio
-1.70
BIOX Fundamentals
Price
$1.43
Prev Close
$1.57
Open
$1.59
50D MA
$1.70
Beta
0.82
Avg. Volume
1.39M
EPS (Annual)
-$0.8764
P/B
0.37
Rev/Employee
$443,866.83
Loading...
Loading...
News
all
press releases
Bioceres Crop Solutions (NASDAQ:BIOX) Price Target Cut to $2.25 by Analysts at Canaccord Genuity Group
Canaccord Genuity Group lowered their target price on shares of Bioceres Crop Solutions from $2.50 to $2.25 and set a "hold" rating on the stock in a research report on Friday...
MarketBeat·4d ago
News Placeholder
More News
News Placeholder
Bioceres Crop Solutions (NASDAQ:BIOX) Posts Earnings Results, Misses Expectations By $0.08 EPS
Bioceres Crop Solutions (NASDAQ:BIOX - Get Free Report) announced its quarterly earnings results on Wednesday. The company reported ($0.12) EPS for the quarter, missing the consensus estimate of...
MarketBeat·7d ago
News Placeholder
Bioceres Crop (BIOX) Reports Q1 Loss, Lags Revenue Estimates
Bioceres Crop (BIOX) delivered earnings and revenue surprises of -200.00% and -18.37%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·8d ago
News Placeholder
Bioceres Crop Solutions Reports Fiscal First Quarter 2026 Financial and Operational Results
Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ: BIOX), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops...
Business Wire·8d ago
News Placeholder
Dole (DOLE) Lags Q3 Earnings Estimates
Dole (DOLE) delivered earnings and revenue surprises of -5.88% and +1.33%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·10d ago
News Placeholder
Bioceres Crop Solutions to Host Fiscal First Quarter 2026 Financial Results Conference Call on Thursday, November 13, 2025 at 8:30 a.m. Eastern Time
Bioceres Crop Solutions Corp. (NASDAQ: BIOX) (Bioceres or the Company), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems...
Business Wire·21d ago
News Placeholder
Bioceres Crop (BIOX) Reports Q3 Loss, Misses Revenue Estimates
Zacks·6mo ago
News Placeholder
HSBC shuffles MedTech stocks, cutting 4, upgrading 2
Investing.com -- HSBC has reshuffled its ratings across the MedTech and Life Sciences sector, upgrading Siemens Healthineers AG (ETR:SHLG) and Sonova (SIX:SOON) to Buy while cutting Align Technology (NASDAQ:ALGN), Eurofins Scientific SE (EPA:EUFI), IQVIA, and Smith&Nephew (LON:SN) to Hold.
investing.com·7mo ago
News Placeholder
Biomerieux projects strong 2025 growth as molecular sales outperform expectations
investing.com·9mo ago
News Placeholder
Bioceres Crop Solutions Updates Second Fiscal Quarter 2025 Expectations
Bioceres Crop Solutions Corp. (NASDAQ: BIOX) today provided preliminary revenues, gross profit and adjusted EBITDA for the fiscal second quarter, ended December 31, 2024. Second quarter revenues are...
Business Wire·10mo ago

Latest BIOX News

View

Advertisement|Remove ads.

Advertisement|Remove ads.